Nanotechnology in vaccine delivery☆

@article{Peek2008NanotechnologyIV,
  title={Nanotechnology in vaccine delivery☆},
  author={Laura J. Peek and C. Middaugh and C. Berkland},
  journal={Advanced Drug Delivery Reviews},
  year={2008},
  volume={60},
  pages={915 - 928}
}
  • Laura J. Peek, C. Middaugh, C. Berkland
  • Published 2008
  • Medicine
  • Advanced Drug Delivery Reviews
  • Abstract With very few adjuvants currently being used in marketed human vaccines, a critical need exists for novel immunopotentiators and delivery vehicles capable of eliciting humoral, cellular and mucosal immunity. Such crucial vaccine components could facilitate the development of novel vaccines for viral and parasitic infections, such as hepatitis, HIV, malaria, cancer, etc. In this review, we discuss clinical trial results for various vaccine adjuvants and delivery vehicles being… CONTINUE READING
    Nanocarriers’ entry into the cell: relevance to drug delivery
    • 1,112
    Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.
    • 311
    Nanoparticle vaccines.
    • 208
    • Highly Influenced

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 245 REFERENCES
    A
    • 99,452
    • PDF
    Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
    • 585
    G
    • 155,096
    • PDF
    H
    • 160,792
    • PDF
    Microparticles as vaccine adjuvants and delivery systems
    • 203